Medication info

Empagliflozin and Metformin Hydrochloride Tablets 12.5/500 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pale brownish purple, oval, biconvex film-coated tablets
Packaging
10 tablets/box [(10 tablets/PTP X 1)], 60 tablets/box [(10 tablets/PTP X 6)], 60 tablets/bottle
Approval status
Active

MFDS item code 202302641 · Approved 2023.09.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular disease
View approved original text

This medication is administered as an adjunct to diet and exercise to improve blood sugar control in adult patients with Type 2 diabetes. It is particularly effective for patients whose blood sugar is not adequately controlled, and precautions related to its use must be observed in patients with established cardiovascular disease. This medication helps to manage blood sugar levels reliably and aids in the prevention of diabetes-related complications.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication can cause a rare but serious metabolic complication known as severe lactic acidosis, so patients with impaired kidney function or those with respiratory disease, sepsis, etc. should exercise caution. Additionally, when used in combination with insulin or sulfonylurea drugs, the risk of severe hypoglycemia may increase, so dose adjustments may be necessary to reduce the risk of hypoglycemia. This medication should not be administered to patients with moderate or severe renal impairment or in situations where acute kidney injury is suspected, and it should also be temporarily discontinued before and after surgery or radiologic examination requiring contrast agents. It is advisable not to use this medication during pregnancy or breastfeeding. This drug may increase the risk of urinary tract infections or genital infections, and if symptoms of infection occur, immediate consultation with healthcare professionals is recommended. Fluid loss may occur during treatment, so caution should be exercised if there are signs of dehydration or hypotension, especially in elderly patients or those with cardiovascular diseases. Long-term use may lead to vitamin B12 deficiency, therefore regular blood testing is recommended. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided during treatment. Some blood sugar monitoring methods may not be appropriate for accurately assessing blood sugar control while taking this medication, so blood sugar should be monitored as directed by healthcare professionals. This medication is not recommended for children under 18 years of age, and in elderly patients, dose adjustments should be made while regularly monitoring renal function. In case of overdose, individuals should seek medical attention immediately, and in severe cases, dialysis may be required. Finally, this medication should be kept out of the reach of children and stored in its original container.

Side effects

Hypoglycemia, urinary tract infection, genital infection, increased urination, ketoacidosis, lactic acidosis, decreased vitamin B12 absorption, decreased fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, altered taste, itching, rash, hives, erythema, angioedema, urination difficulties, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, vaginismus, vulvitis, balanitis, perineal necrosis, fluid volume loss, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting), decreased serum vitamin B12 concentration, chronic gastritis, constipation, gastritis, abdominal discomfort, anal incontinence, dry mouth, gastrointestinal dysfunction, gastroesophageal reflux disease, oral discomfort, salivary gland pain, headache, sensory impairment, orthostatic dizziness, dizziness, cerebral infarction, weakness, chest discomfort, chest pain, ankle fracture, epicondylitis, facial bone fracture, musculoskeletal pain, hypercholesterolemia, dyslipidemia, vitamin D deficiency, nasopharyngitis, soft tissue infection, pneumonia, upper respiratory tract infection, urinary stones, vulvar pruritus, benign prostatic hyperplasia, diabetic retinopathy, double vision, hypertension, insomnia, epigastric pain, cavities, gastric ulcer, erosive gastritis, abdominal distension, anal bleeding, ischemic colitis, enteritis, bloating, gastric polyps, gingival edema, blood stool excretion, hemorrhoids, colon bleeding, pancreatic cyst, rectal pain, toothache, dyspepsia, gastritis, upper respiratory tract infection, bronchitis, chronic sinusitis, gastroenteritis, Helicobacter infection, periodontitis, appendiceal abscess, appendicitis, chronic tonsillitis, conjunctivitis, influenza, laryngitis, meningitis, chronic otitis media, paronychia, peritonsillar abscess, pulmonary tuberculosis, sepsis, subcutaneous abscess, tinea corporis, dental abscess, salpingo-oophoritis, vestibular neuritis, orthostatic dizziness, sensory abnormalities, amnesia, carotid artery stenosis, diabetic neuropathy, facial paralysis, intracranial aneurysm, memory impairment, neuralgia, Parkinsonism, polyneuropathy, sensory impairment, drowsiness, CNS-origin vertigo, fatigue, peripheral edema, facial edema, peripheral swelling, fever, facial swelling, chills, unusual sensations, swelling, pain, pain at the puncture site, vascular stent stenosis, vascular stent thrombosis, weight gain, abnormal ECG, decreased hemoglobin, increased hemoglobin, positive Helicobacter test, positive urine red blood cells, chronic kidney disease, hematuria, overactive bladder, renal mass, urinary retention, urinary pain, abnormal urination, erectile dysfunction, atrophic vaginitis, cervical dysplasia, cervical inflammation, scrotal pain, sexual dysfunction, vaginal discharge, hypoglycemia, decreased appetite, obesity, thirst, diabetes, hyperlipidemia, hyponatremia, dermoid cyst, seborrheic dermatitis, atopic dermatitis, diabetic foot, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, arthralgia, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurry vision, corneal erosion, macular fibrosis, ocular discomfort, ocular congestion, pathological myopia, retinal detachment, retinal crystals, retinal vein occlusion, serous retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, nasal bleeding, asthma, exertional dyspnea, wet cough, allergic rhinitis, residual phlegm, skin laceration, rib fracture, ligamentous syndrome, angina, palpitations, Prinzmetal angina, coronary artery disease, tachycardia, atherosclerosis, deep vein thrombosis, diabetic vascular complications, peripheral artery occlusive disease, anxiety, depression, sleep disorders, acute cholecystitis, autoimmune hepatitis, cholelithiasis, hepatitis, otalgia, orthostatic dizziness, vertigo, anemia, lymphadenopathy, hypothyroidism, thyroid nodule, unstable angina

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a sealed container to protect it from air and moisture, and it is recommended to store it at room temperature between 1°C and 30°C. Proper storage will help maintain the efficacy of the medication.

Appearance and packaging

Appearance

Pale brownish purple, oval, biconvex film-coated tablets

Package unit

10 tablets/box [(10 tablets/PTP X 1)], 60 tablets/box [(10 tablets/PTP X 6)], 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.